Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
30.2M
-
Shares change
-
+225K
-
Total reported value, excl. options
-
$408M
-
Value change
-
+$2.29M
-
Put/Call ratio
-
2.36
-
Number of buys
-
45
-
Number of sells
-
-21
-
Price
-
$13.50
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q4 2021
88 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2021.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.2M shares
of 61M outstanding shares and own 49.56% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (5.84M shares), FMR LLC (5.41M shares), Redmile Group, LLC (3.08M shares), CHI Advisors LLC (2.57M shares), TRV GP IV, LLC (2.13M shares), BlackRock Inc. (1.69M shares), CITADEL ADVISORS LLC (1.34M shares), VANGUARD GROUP INC (1.22M shares), Point72 Asset Management, L.P. (1.14M shares), and HARVARD MANAGEMENT CO INC (562K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.